Hypomyelination and congenital cataract is a recently reported autosomal recessive white matter disorder characterized by hypomyelination of the central and peripheral nervous systems, progressive neurological impairment and congenital cataract and caused by mutations in gene DRCTNNB1A. Here we report a large intragenic deletion that does not lead to congenital cataract in all of the patients in an afflicted family. The clinical phenotypes described for five patients broaden the phenotype of the disease and indicate that congenital cataract is not an essential criterion for differential diagnosis.
Introduction
Hypomyelination and congenital cataract (HCC) is a new white matter disorder characterized by hypomyelination of the central and peripheral nervous systems, progressive neurological impairment and congenital cataract. This disease was reported recently by Zara et al, 1 who also identified the gene responsible as DRCTNNB1A. Here we report genetic analyses in a large consanguineous family from Eastern Turkey and detailed clinical features in one of the five affected individuals. The clinical evaluation, together with identification of a large deletion encompassing two exons of DRCTNNB1A, allowed us to assign the disorder as HCC. However, we report on one patient who developed bilateral cataract at 9 years of age and another patient with persistent unilateral cataract at 12 years of age.
Methods

Subjects
The large consanguineous family who applied to us for a genetic study had five affected members, three of whom survived 10, 13 and 16 years, respectively ( Figure 1 ). This study has been approved by the Committee on Research with Human Participants at Bogazic¸i University.
Molecular studies
A genome scan 2 for the family at NHLBI Mammalian Genotyping Service (contract no. HV48141), followed by statistical analysis and fine-mapping identified a 9.02-Mb gene locus between markers D7S493 and D7S632 ( Figure 1 ). This locus included gene DRCTNNB1A reported later as responsible for HCC by Zara et al. 1 We analyzed 10 of the 11 coding exons of the gene in our patients. Exon 11 was not analyzed, since it is part of a low-expressed isoform. The sequences of intronic primers flanking each exon together with splice junctions were as reported, 1 
Results
Clinical studies
A detailed clinical investigation was available for one patient only, whereas for the other four patients clinical information was partial and no instrumental investigations were available. The clinical manifestations of all five patients were similar to those described in Zara et al, Figure 1 online) . Paraventricular white matter comprising the temporal horns, internal and external capsules, corona radiata and centrum semiovale were involved symmetrically in both the anterior and posterior parts of the cerebral hemispheres. Slight cerebral atrophy was also observed. Low nerve conduction velocities measured at age 2.4 years, ranging from 20 to 30 m/s in sensory and motor nerves, accompanied by prolonged F-response and by denervation potentials on EMG, verified a sensory -motor peripheral demyelinating neuropathy. Available clinical findings for the affected children are summarized in Table 1 . Patients 502 and 505 were deceased at the time of the study; therefore, DNA and detailed clinical reports from these individuals were not available. Patient 502 died at the age of 2 years during the operation for the recurrent cataract. The parents of patient 505 stated that she had congenital cataract only unilaterally, and whether she later developed it in the other eye is not known. Her death at the age of 12 years was attributed to the disease.
Molecular studies
The disease gene was linked to a 9.02-Mb region with a maximum multipoint LOD score of 4.41 in the interval D7S2510 -D7S2492 (Supplementary Figure 2 online ). This region contained 92 genes, including DRCTNNB1A, which was responsible for HCC. 1 We analyzed exons 1 -7, 10 and 12 by SSCP, but did not observe any aberrant pattern in the three patients available for molecular study. However, exons 8 and 9 were refractory to PCR amplification, suggesting the presence of a homozygous deletion mutation. Amplification using intronic primers P1_delF and P1_delR yielded an approximately 2-kb fragment rather than the 6.3-kb fragment observed from the normal individuals, supporting the presence of a deletion (Supplementary Figure 3a online). Sequence analysis of the small fragment identified a deletion of 4084 nt encompassing exons 8 and 9 (Supplementary Figure 3b on line) . The region of the deletion is flanked by an 82-and 83-bp direct repeat. In the mutant allele, a 4001-bp region together with the adjacent halves of the flanking repeat copies had been lost. This mutation c.531-439_743 þ 348del is predicted to lead to the shift of the translational reading frame at the beginning of exon 10 and thus the truncation of the protein, 5 codons into the exon.
Discussion
Linkage to 7p together with close clinical resemblance to the disorder reported recently by Zara et al 1 led us to assign the disorder in our patients as HCC. We subsequently showed that our patients carried in the disease gene a homozygous large deletion that apparently resulted from an unequal crossover at the direct copies of an imperfect repeat. The mutation would cause skipping of exons 8 and 9, and due to the 1-nt shift in the translational reading frame, is predicted to lead to a premature stop codon at position 214. The truncation deletes 308 amino-acid residues from the C terminus of the native 521 amino-acid protein. This mutation c.531-439_743 þ 348del is predicted to result in absence of the protein since the deleted region spans more than half the coding region, including amino acids 230 -248, which comprise one of the two putative transmembrane segments reported by Zara et al. 1 The mutations reported in the mentioned study are either splice site (c.51 þ 1G4A and c.414 þ 1G4T) or missense (c.158T4C). It is difficult to speculate on the relative severities of the splicing and truncating mutations. All 10 patients in the previous report 1 could walk with support until at least age 8 years, while none of our four patients who survived beyond age 2 years could walk with support past 6 years. However, while all patients in the former study had bilateral congenital cataracts, two of our patients did not: patient 509 developed cataracts at age 9 years and her sister (patient 505) had cataract seemingly only unilaterally until she died at the age of 12 years. Our findings add to the clinical variability reported already, 1 in that congenital or bilateral cataract should not be considered a prerequisite for the diagnosis of HCC. Especially in isolated cases, bilateral or congenital cataract as a criterion for HCC would lead to misdiagnosis. 
